William J. Tipping

Dr. William J. Tipping

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 February 2016 in Chemical Society Reviews
Verified
Journal Article
Open access
PDF file
WTWilliam J. Tipping
William J. Tipping
MLM. Lee
M. Lee
ASA. Serrels
A. Serrels
VBV. G. Brunton
V. G. Brunton
AHAlison Hulme
Alison Hulme
Stimulated Raman scattering and the use of bioorthogonal tags provide novel imaging platforms to facilitate the drug discovery process.

24 May 2017 in Chemical Science
Verified
Journal Article
Open access
PDF file
WTWilliam J. Tipping
William J. Tipping
MLMartin Lee
Martin Lee
ASAlan Serrels
Alan Serrels
VBValerie G. Brunton
Valerie G. Brunton
AHAlison Hulme
Alison Hulme
Stimulated Raman scattering (SRS) microscopy in tandem with bioorthogonal Raman labelling enables intracellular drug concentrations, distribution and therapeutic response to be measured in living cells.

3 March 2019 in Nanomaterials
Verified
Journal Article
Open access
PDF file
SVSally Vanden-Hehir
Sally Vanden-Hehir
WTWilliam J. Tipping
William J. Tipping
MLMartin Lee
Martin Lee
VBValerie G. Brunton
Valerie G. Brunton
AWAnna Williams
Anna Williams
AHAlison Hulme
Alison Hulme
The efficacy of pharmaceutical agents can be greatly improved through nanocarrier delivery. Encapsulation of pharmaceutical agents into a nanocarrier can enhance their bioavailability and biocompatibility, whilst also facilitating targeted drug delivery to specific locations within the body. However, detailed understanding of the in vivo activity of the nanocarrier-drug conjugate is required prior to regulatory approval as a safe and effective treatment strategy. A comprehensive understanding of how nanocarriers travel to, and interact with, the intended target is required in order to optimize the dosing strategy, reduce potential off-target effects, and unwanted toxic effects. Raman spectroscopy has received much interest as a mechanism for label-free, non-invasive imaging of nanocarrier modes of action in vivo. Advanced Raman imaging techniques, including coherent anti-Stokes Raman scattering (CARS) and stimulated Raman scattering (SRS), are paving the way for rigorous evaluation of nanocarrier activity at the single-cell level. This review focuses on the development of Raman imaging techniques to study organic nanocarrier delivery in cells and tissues.

2 July 2020 in The Analyst
Verified
Journal Article
Open access
PDF file
LWLiam T. Wilson
Liam T. Wilson
WTWilliam J. Tipping
William J. Tipping
LJLauren E. Jamieson
Lauren E. Jamieson
CWCorinna Wetherill
Corinna Wetherill
ZHZoë Henley
Zoë Henley
NTNicholas C. O. Tomkinson
Nicholas C. O. Tomkinson
Probes based on Alkyne Tag Raman Imaging offer an entirely new platform for the sensing of pH i .

17 March 2022 in Cancers
Verified
Journal Article
Open access
PDF file
FGFortis Gaba
Fortis Gaba
WTWilliam J. Tipping
William J. Tipping
MSMark Salji
Mark Salji
KFKaren Faulds
Karen Faulds
DGDuncan Graham
Duncan Graham
HLHing Leung
Hing Leung
Optical techniques are widely used tools in the visualisation of biological species within complex matrices, including biopsies, tissue resections and biofluids. Raman spectroscopy is an emerging analytical approach that probes the molecular signature of endogenous cellular biomolecules under biocompatible conditions with high spatial resolution. Applications of Raman spectroscopy in prostate cancer include biopsy analysis, assessment of surgical margins and monitoring of treatment efficacy. The advent of advanced Raman imaging techniques, such as stimulated Raman scattering, is creating opportunities for real-time in situ evaluation of prostate cancer. This review provides a focus on the recent preclinical and clinical achievements in implementing Raman-based techniques, highlighting remaining challenges for clinical applications. The research and clinical results achieved through in vivo and ex vivo Raman spectroscopy illustrate areas where these evolving technologies can be best translated into clinical practice.

25 February 2022 in Chemical Science
Verified
Journal Article
Open access
PDF file
WTWilliam J. Tipping
William J. Tipping
LWLiam T. Wilson
Liam T. Wilson
CAConnie An
Connie An
ALAristea A. Leventi
Aristea A. Leventi
Alastair W. WarkAlastair W. Wark
Alastair W. Wark
DGDuncan Graham
Duncan Graham
Statins have displayed significant, although heterogeneous, anti-tumour activity in breast cancer disease progression and recurrence. They offer promise as a class of drugs, normally used for cardiovascular disease control, that could have a significant impact on the treatment of cancer. Understanding their mode of action and accurately assessing their efficacy on live cancer cells is an important and significant challenge. Stimulated Raman scattering (SRS) microscopy is a powerful, label-free imaging technique that can rapidly characterise the biochemical responses of live cell populations following drug treatment. Here, we demonstrate multi-wavelength SRS imaging together with spectral phasor analysis to characterise a panel of breast cancer cell lines (MCF-7, SK-BR-3 and MDA-MB-231 cells) treated with two clinically relevant statins, atorvastatin and rosuvastatin. Label-free SRS imaging within the high wavenumber region of the Raman spectrum (2800–3050 cm−1) revealed the lipid droplet distribution throughout populations of live breast cancer cells using biocompatible imaging conditions. A spectral phasor analysis of the hyperspectral dataset enables rapid differentiation of discrete cellular compartments based on their intrinsic SRS characteristics. Applying the spectral phasor method to studying statin treated cells identified a lipid accumulating phenotype in cell populations which displayed the lowest sensitivity to statin treatment, whilst a weaker lipid accumulating phenotype was associated with a potent reduction in cell viability. This study provides an insight into potential resistance mechanisms of specific cancer cells towards treatment with statins. Label-free SRS imaging provides a novel and innovative technique for phenotypic assessment of drug-induced effects across different cellular populations and enables effective analysis of drug–cell interactions at the subcellular scale.